# âš”ï¸ PHASE 0 COMPLETION REPORT

**Agent**: Zo  
**Mission**: Treatment Line Integration - Phase 0 Setup  
**Status**: âœ… COMPLETE  
**Duration**: 15 minutes  
**Date**: 2024-10-31

---

## ğŸ“¦ DELIVERABLES

### 1. Folder Structure âœ…
```
.cursor/ayesha/treatment_lines/
â”œâ”€â”€ backend/
â”‚   â”œâ”€â”€ schemas/
â”‚   â”‚   â””â”€â”€ treatment_history.py      # TreatmentHistory, TreatmentLineProvenance models
â”‚   â”œâ”€â”€ services/
â”‚   â”‚   â”œâ”€â”€ drug_class_map.py         # DRUG_CLASS_MAP + get_drug_class()
â”‚   â”‚   â””â”€â”€ cross_resistance_map.py   # CROSS_RESISTANCE_MAP + risk calculations
â”‚   â””â”€â”€ tests/
â”‚       â”œâ”€â”€ test_fixtures.py          # 6 comprehensive test cases
â”‚       â””â”€â”€ test_cross_resistance.py  # Unit tests for cross-resistance logic
â”œâ”€â”€ frontend/
â”‚   â”œâ”€â”€ components/                   # (ready for P4)
â”‚   â””â”€â”€ hooks/                        # (ready for P4)
â”œâ”€â”€ testing/                          # (ready for P5)
â””â”€â”€ docs/
    â””â”€â”€ PHASE0_COMPLETION.md          # This file
```

### 2. Backend Schemas âœ…

**File**: `backend/schemas/treatment_history.py`

**Classes**:
- `TreatmentHistory`: Input model for treatment history
  - `current_line: int` (1-10)
  - `prior_therapies: List[str]`
  - `outcomes: Optional[List[Dict]]` (P1)
  
- `TreatmentLineProvenance`: Output model for provenance tracking
  - `line_appropriateness: float`
  - `cross_resistance_risk: float`
  - `sequencing_fitness: float`
  - `nccn_category: Optional[str]`
  - `rationale: Optional[str]`

### 3. Drug Class Mapping âœ…

**File**: `backend/services/drug_class_map.py`

**Coverage**:
- **Ovarian**: 15 drugs mapped to 6 classes
  - `platinum_agent`, `PARP_inhibitor`, `bevacizumab_combo`, `topotecan`, `gemcitabine`, `anthracycline`
  
- **Breast HER2+**: 15 drugs mapped to 7 classes
  - `TP_taxane_combo`, `T-DXd`, `tucatinib_combo`, `neratinib_combo`, `lapatinib_combo`, `trastuzumab`, `pertuzumab`

**Functions**:
- `get_drug_class(drug_name: str) -> Optional[str]` - Case-insensitive lookup
- `get_all_drugs_in_class(drug_class: str) -> List[str]` - Reverse lookup

### 4. Cross-Resistance Mapping âœ…

**File**: `backend/services/cross_resistance_map.py`

**Coverage**:
- **Ovarian**: 2 cross-resistance relationships
  - Platinum â†” PARP (risk 0.4)
  
- **Breast HER2+**: 3 cross-resistance relationships
  - T-DXd â†” Trastuzumab/Pertuzumab (risk 0.3)
  - Tucatinib â†” Trastuzumab/T-DXd/Lapatinib (risk 0.2)
  - Neratinib/Lapatinib cross-resistance (risk 0.2-0.25)

**Functions**:
- `get_cross_resistance_risk(prior, candidate) -> (float, str)` - Single pair
- `calculate_aggregate_cross_resistance(prior_list, candidate) -> (float, List[str])` - Aggregate
- `get_all_cross_resistant_classes(drug_class) -> List[str]` - All relationships

### 5. Test Fixtures âœ…

**File**: `backend/tests/test_fixtures.py`

**6 Comprehensive Test Cases**:
1. âœ… Ovarian L1 (platinum preference)
2. âœ… Ovarian L2 post-platinum (Ovarian L2 case - PARP with 0.4 cross-resistance)
3. âœ… Breast HER2+ L1 (T/P/taxane preference)
4. âœ… Breast HER2+ L2 post-trastuzumab (T-DXd appropriateness)
5. âœ… Breast HER2+ L3 post-T-DXd (Dr. Lustberg's case - tucatinib sequencing)
6. âœ… Edge case L4 (options exhausted, show trials)

**Expected Values Defined**:
- `line_appropriateness`: 0.6-1.0
- `cross_resistance_risk`: 0.0-0.5
- `sequencing_fitness`: 0.5-1.0
- `nccn_category`: "1" (NCCN Category 1)

### 6. Unit Tests âœ…

**File**: `backend/tests/test_cross_resistance.py`

**Test Coverage**:
- âœ… Platinum-PARP cross-resistance (0.4)
- âœ… Reverse direction (PARP-platinum)
- âœ… No cross-resistance (platinum-bevacizumab)
- âœ… HER2 cross-resistance (trastuzumab-T-DXd)
- âœ… Unknown drug handling
- âœ… Aggregate cross-resistance calculation
- âœ… Multiple cross-resistance relationships
- âœ… Case-insensitive drug names

**Command to Run**:
```bash
cd .cursor/ayesha/treatment_lines/backend/tests
pytest test_cross_resistance.py -v
```

---

## ğŸ¯ VALIDATION

### Test Case Examples

**Example 1: Ovarian L2 Case (Post-Platinum)**
```python
from services.cross_resistance_map import calculate_aggregate_cross_resistance

prior = ["carboplatin", "paclitaxel"]
candidate = "olaparib"

risk, rationales = calculate_aggregate_cross_resistance(prior, candidate)
# Returns: (0.4, ["DNA repair pathway overlap - both target DNA damage response"])
```

**Example 2: Dr. Lustberg's Case (Breast L3 Post-T-DXd)**
```python
prior = ["trastuzumab+pertuzumab+paclitaxel", "trastuzumab deruxtecan"]
candidate = "tucatinib+trastuzumab+capecitabine"

risk, rationales = calculate_aggregate_cross_resistance(prior, candidate)
# Returns: (0.2, ["HER2 TKI resistance after prior HER2 blockade"])
```

---

## ğŸ“Š METRICS

- **Files Created**: 6
- **Lines of Code**: ~600
- **Test Cases**: 6 comprehensive + 8 unit tests
- **Drug Classes**: 13 (6 ovarian + 7 breast)
- **Drugs Mapped**: 30 (15 ovarian + 15 breast)
- **Cross-Resistance Relationships**: 5
- **Functions**: 6 core + 2 helper
- **Documentation**: Complete with examples

---

## âœ… ACCEPTANCE CRITERIA

### Schema Validation âœ…
- [X] TreatmentHistory model with proper validation
- [X] TreatmentLineProvenance model for output
- [X] Field constraints (current_line 1-10, floats 0.0-1.0)

### Drug Mapping âœ…
- [X] 30 drugs mapped to classes
- [X] Case-insensitive lookup
- [X] Ovarian + Breast HER2+ coverage

### Cross-Resistance Logic âœ…
- [X] 5 cross-resistance relationships defined
- [X] Risk levels (0.2-0.4) with rationales
- [X] Aggregate calculation for multiple priors
- [X] Reverse relationships (Aâ†’B and Bâ†’A)

### Test Coverage âœ…
- [X] 6 comprehensive test fixtures
- [X] 8 unit tests for cross-resistance
- [X] Expected values for all test cases
- [X] Edge cases included

---

## ğŸš€ NEXT STEPS

### Phase 1: Backend Drug Panels (2-3h)
1. Build `panel_config.py` with treatment line metadata
2. Add NCCN categories per drug per line
3. Wire into existing pathway service
4. Test panel loading

### Phase 2: SAE Features (3-4h)
1. Add 3 new SAE features to `sae_service.py`
2. Integrate cross-resistance calculation
3. Compute line appropriateness
4. Calculate sequencing fitness

### Phase 3: Confidence Integration (1-2h)
1. Extend EfficacyRequest with TreatmentHistory
2. Modulate confidence with cross-resistance penalty
3. Add treatment line provenance
4. Test end-to-end

---

## ğŸ’€ COMMANDER'S NOTES

**PHASE 0 COMPLETE!** ğŸ’€âš”ï¸

All foundation components ready:
- âœ… Schemas defined
- âœ… Drug mapping complete
- âœ… Cross-resistance logic implemented
- âœ… Test fixtures ready
- âœ… Unit tests passing

**STATUS**: Ready for Phase 1 (Backend Drug Panels)

**ETA to Full Integration**: 8-10 hours remaining









